Dementia affects over 55 million people worldwide. The World Health Organization projects that number will reach 139 million by 2050. The disease develops over years before anyone catches it clinically, and that gap between biological onset and recognition is one of the hardest problems in dementia care. By the time a patient shows obvious cognitive symptoms, the brain has already sustained real damage.
Recent research points to measurable changes in heart rate variability, cardiovascular regulation, and respiratory patterns that track alongside cognitive decline. These happen to be the same physiological signals that camera-based vital sign monitoring captures continuously and passively. The overlap between what rPPG technology measures and what researchers are finding in dementia patients deserves a close look.
"Lower heart rate variability is associated with worse memory function, independent of demographic and cardiovascular risk factors." — Okoro et al., The Maastricht Study, Journal of Alzheimer's Disease (2025)
The autonomic nervous system and cognitive decline
The brain does not deteriorate in isolation. Alzheimer's disease and related dementias damage brain regions that handle both cognition and autonomic function. The insular cortex, anterior cingulate, and brainstem nuclei are involved in cognitive processing and autonomic regulation alike. When these areas degrade, both domains show changes.
Early research by Algotsson et al., published in the Journal of the Neurological Sciences (1995), found that Alzheimer's disease patients showed impaired parasympathetic cardiovascular function compared to age-matched controls. R-R interval variation, a measure of cardiac vagal tone, was significantly reduced in the AD group. This was nearly three decades ago, and the finding has been replicated repeatedly since.
More recently, a systematic review by Giulietti et al., published in the Journal of Clinical Medicine (2024), examined longitudinal studies connecting HRV to cognitive outcomes. The review found a consistent association: higher parasympathetic nervous system activity correlated with better cognitive performance, while reduced HRV predicted cognitive decline across multiple populations and follow-up periods.
The connection goes beyond statistics. The vagus nerve directly connects the heart and the brain. Vagal tone influences neuroinflammation, cerebral blood flow, and neurotransmitter balance. When vagal function declines, the brain loses a protective input, and cognitive function tends to follow.
What the research shows: HRV and cognitive performance
Several large-scale studies have now quantified the relationship between HRV and cognitive function in older adults.
| Study | Population | Key finding | HRV measure used |
|---|---|---|---|
| Okoro et al., Maastricht Study (2025) | 2,000+ adults aged 40-75 | Lower HRV associated with worse memory function independent of cardiovascular risk | SDNN, RMSSD |
| Derby et al., Einstein Aging Study (2025) | 590 older adults (mean age 79) | Reduced HRV linked to lower cognitive performance and higher rates of cognitive impairment | Time and frequency domain measures |
| Giulietti et al., systematic review (2024) | 13 longitudinal studies | Consistent association between higher parasympathetic activity and better cognition | Multiple HRV indices |
| PubMed meta-analysis (2025) | Multi-cohort | HRV related to cognitive functioning and may serve as early Alzheimer's biomarker, though predictive strength varies | SDNN, HF power |
| Algotsson et al. (1995) | 23 AD patients vs. 23 controls | Impaired parasympathetic function in Alzheimer's patients | R-R interval variation |
Derby et al. at the Albert Einstein College of Medicine published cross-sectional results from the Einstein Aging Study in 2025, analyzing 590 participants with a mean age of 79. They found that reduced HRV was associated with both lower cognitive test scores and a higher prevalence of mild cognitive impairment. The relationship held across time-domain and frequency-domain HRV measures, suggesting that the autonomic-cognitive link is robust rather than dependent on a single measurement approach.
The Maastricht Study, one of the largest population-based cohort studies examining cardiometabolic diseases, added important data in 2025. Okoro et al. analyzed over 2,000 participants and found that lower HRV specifically predicted worse memory function. The association remained significant after adjusting for age, sex, education, and cardiovascular risk factors. Memory is often the first cognitive domain affected in Alzheimer's disease, making this finding particularly relevant for early screening.
A caveat worth noting: a 2025 study examined whether HRV could predict cognitive and pathophysiological brain markers assessed eight and thirteen years later. The results were mixed. Predictive power for long-term brain changes was limited once coronary calcification was accounted for. HRV is not going to single-handedly predict dementia. It is one piece of a larger physiological picture.
Why continuous monitoring matters for cognitive screening
Cognitive decline is gradual. A single HRV measurement taken at a doctor's office tells you about that moment, but cognitive deterioration plays out over months and years. Clinicians need trend data showing how autonomic function changes over time in a given individual, and that requires a different monitoring approach.
Traditional HRV assessment requires an ECG or a wearable heart rate monitor. For elderly populations, especially those already experiencing cognitive impairment, compliance with wearable devices is a real problem. Patients forget to charge them, refuse to wear them, or remove them repeatedly. A 2025 JMIR Aging systematic review on remote monitoring for Alzheimer's patients found that adherence to wearable monitoring devices drops substantially in populations with moderate to severe cognitive impairment.
Camera-based vital sign monitoring sidesteps the compliance problem. A camera positioned in a living room or bedroom captures heart rate, HRV, and respiratory data without requiring the patient to do anything. No devices to charge, no sensors to attach, nothing to remember. For a population that increasingly cannot manage technology, passive monitoring makes practical sense.
A Frontiers in Digital Health review by Di Lernia et al. (2025) on rPPG health assessment found that the technology has reached sufficient accuracy for heart rate and HRV extraction in clinical and research contexts. Mean absolute errors for heart rate sit consistently below 3 bpm in controlled settings, and HRV metrics like SDNN and RMSSD can be extracted from rPPG signals with reasonable agreement to ECG-derived values.
Clinical applications in elderly care settings
Residential care facilities monitor dozens or hundreds of residents, and cognitive screening typically happens on scheduled intervals, often months apart. Between screenings, gradual changes go unnoticed until they cross a clinical threshold.
Continuous vital sign monitoring in care facilities could change this. Tracking individual HRV baselines over weeks and months would let staff flag residents whose autonomic function is declining faster than expected for their age. Overnight respiratory and heart rate monitoring can identify sleep disruptions, which are both an early symptom and a risk factor for dementia. Physiological stress responses may indicate pain or agitation in patients who can no longer say what they are feeling. And objective physiological data gives clinicians something concrete to pair with subjective cognitive assessments.
A scoping review published in Frontiers in Public Health (2023) examined monitoring technologies for older adults with cognitive impairment. The review found that camera-based systems showed promise for behavioral and physiological monitoring, but noted that rigorous validation studies in dementia populations remain limited. The technology works and the biological rationale is sound, but clinical trials specifically connecting camera-based HRV monitoring to earlier dementia detection have not yet been completed.
The NIH-funded Remote Cognitive Aging and Alzheimer's Disease Assessment project, registered through the NIH Reporter system, is working on validating remote assessment tools for cognitive aging. While this project focuses on digital cognitive tests rather than physiological monitoring, it reflects a broader shift toward remote and continuous assessment that aligns with what camera-based vital sign monitoring can provide.
Beyond HRV: respiratory rate and sleep patterns
Heart rate variability gets most of the attention in the autonomic-cognition literature, but it is not the only relevant vital sign.
Respiratory rate disturbances during sleep, particularly sleep-disordered breathing, have been independently linked to cognitive decline. A meta-analysis in the American Journal of Respiratory and Critical Care Medicine found that obstructive sleep apnea increases the risk of developing dementia by approximately 26%. Continuous overnight respiratory monitoring through camera-based systems could identify residents with undiagnosed sleep-disordered breathing, which is treatable and potentially modifiable as a dementia risk factor.
Blood pressure variability, measured through pulse wave analysis, also shows associations with cognitive decline. Visit-to-visit blood pressure variability, beyond just absolute blood pressure levels, has been linked to faster cognitive deterioration and white matter disease in longitudinal studies. While camera-based blood pressure measurement remains experimental, pulse transit time estimation from rPPG signals is an active area of development.
Multiple vital sign parameters tracked continuously will likely prove more informative than any single marker. Cognitive decline involves cascading failures across multiple regulatory systems. Monitoring that captures several physiological dimensions at once gives a richer picture than isolated measurements.
Where this research is heading
The pieces are converging, though nobody has assembled them into a clinical workflow yet. HRV is linked to cognitive decline across multiple studies. Camera-based systems can measure HRV continuously and passively. Elderly populations benefit from contactless approaches. What remains is the validation work: prospective clinical trials that specifically test whether continuous camera-based HRV monitoring can identify individuals progressing toward dementia earlier than current screening methods.
Digital cognitive assessment platforms are also evolving rapidly. A 2025 review in PMC examined remote digital cognitive assessments using smartphone and tablet-based tests. Combining physiological monitoring with periodic digital cognitive testing could create a two-channel screening approach: the camera watches the body's autonomic signals continuously, while brief digital tests assess cognitive function at intervals. When both channels show decline simultaneously, the case for clinical follow-up gets considerably stronger.
Circadify has developed camera-based vital sign measurement technology that captures heart rate, HRV, respiratory rate, and SpO2 from a standard device camera. As the evidence base connecting autonomic biomarkers to cognitive decline continues to grow, camera-based monitoring is positioned to play a role in how aging populations are monitored for early signs of neurodegenerative disease.
Frequently Asked Questions
Can camera-based monitoring detect dementia?
Camera-based monitoring does not diagnose dementia. It measures physiological parameters like heart rate variability and respiratory rate that research has linked to cognitive decline. Changes in these markers over time could flag individuals who warrant clinical cognitive assessment, but the technology measures vital signs, not cognitive function directly.
What is the connection between heart rate variability and cognitive decline?
Lower heart rate variability is associated with reduced parasympathetic nervous system activity, which multiple studies have linked to poorer cognitive performance and increased risk of cognitive impairment. The autonomic nervous system and the brain share regulatory pathways, so changes in autonomic function often parallel changes in cognitive function.
How could contactless monitoring help with dementia screening in elderly care?
Contactless monitoring can passively track vital sign patterns over weeks and months without requiring patient compliance or wearable devices. For elderly populations, especially those with cognitive impairment who may resist wearing sensors, camera-based monitoring provides continuous physiological data that clinicians could use alongside cognitive assessments to identify early changes.
Is heart rate variability a reliable biomarker for Alzheimer's disease?
HRV shows consistent associations with cognitive performance across multiple studies, but it is not yet established as a standalone diagnostic biomarker for Alzheimer's disease. Research from the Maastricht Study and Einstein Aging Study found significant links between lower HRV and worse memory function, though the relationship involves multiple confounding factors including cardiovascular health and age.